Hiromasa Inoue - Search Results

Year	Number of Results
2002	3
2003	5
2004	12
2005	17
2006	19
2007	9
2008	10
2009	9
2010	12
2011	18
2012	14
2013	15
2014	14
2015	15
2016	16
2017	14
2018	9
2019	15
2020	7
2021	12
2022	19
2023	20
2024	6

1

The impact of energy and protein intake on rehabilitation efficiency in convalescent patients.

Okamoto K, Kogirima M, Tsuji Y, Ishino S, Inoue H. Okamoto K, et al. Among authors: inoue h. Asia Pac J Clin Nutr. 2024 Mar;33(1):33-38. doi: 10.6133/apjcn.202403_33(1).0004. Asia Pac J Clin Nutr. 2024. PMID: 38494685 Free article.

2

Group III secreted phospholipase A₂ -driven lysophospholipid pathway protects against allergic asthma.

Hamu-Tanoue A, Takagi K, Taketomi Y, Miki Y, Nishito Y, Kano K, Aoki J, Matsuyama T, Kondo K, Dotake Y, Matsuyama H, Machida K, Murakami M, Inoue H. Hamu-Tanoue A, et al. Among authors: inoue h. FASEB J. 2024 Jan 31;38(2):e23428. doi: 10.1096/fj.202301976R. FASEB J. 2024. PMID: 38236184

3

Burden of Uncontrolled Severe Asthma With and Without Elevated Type-2 Inflammatory Biomarkers.

Ding B, Chen S, Rapsomaniki E, Quinton A, Cook W, Reddel HK, Papi A; NOVELTY Scientific Community; NOVELTY study investigators. Ding B, et al. J Allergy Clin Immunol Pract. 2024 Apr;12(4):970-982. doi: 10.1016/j.jaip.2023.12.021. Epub 2023 Dec 22. J Allergy Clin Immunol Pract. 2024. PMID: 38141721 Free article.

4

Identification of Tumor-Suppressive miR-139-3p-Regulated Genes: TRIP13 as a Therapeutic Target in Lung Adenocarcinoma.

Hagihara Y, Tomioka Y, Suetsugu T, Shinmura M, Misono S, Goto Y, Kikkawa N, Kato M, Inoue H, Mizuno K, Seki N. Hagihara Y, et al. Among authors: inoue h. Cancers (Basel). 2023 Nov 24;15(23):5571. doi: 10.3390/cancers15235571. Cancers (Basel). 2023. PMID: 38067275 Free PMC article.

5

Improving visual acuity with nivolumab plus ipilimumab plus two cycles of chemotherapy following a diagnosis of lung adenocarcinoma with choroidal metastasis: A case report and literature review.

Matsuyama T, Oniwa M, Tsuruzono K, Yasuda S, Yone M, Tomioka Y, Uchida A, Mitsuyama H, Kubota S, Suetsugu T, Mizuno K, Inoue H. Matsuyama T, et al. Among authors: inoue h. Respirol Case Rep. 2023 Nov 30;12(1):e01262. doi: 10.1002/rcr2.1262. eCollection 2024 Jan. Respirol Case Rep. 2023. PMID: 38045825 Free PMC article.

6

Risks of dementia in a general Japanese older population with preserved ratio impaired spirometry: The Hisayama Study.

Kawatoko K, Washio Y, Ohara T, Fukuyama S, Honda T, Hata J, Nakazawa T, Kan-O K, Inoue H, Matsumoto K, Nakao T, Kitazono T, Okamoto I, Ninomiya T. Kawatoko K, et al. Among authors: inoue h. J Epidemiol. 2023 Dec 2. doi: 10.2188/jea.JE20230207. Online ahead of print. J Epidemiol. 2023. PMID: 38044087 Free article.

7

Detecting acquired V-Raf murine sarcoma viral oncogene homolog B1 V600E mutation associated with osimertinib resistance in epidermal growth factor receptor-mutant lung adenocarcinoma: A case report.

Hagihara Y, Suetsugu T, Uto H, Kozono T, Masada Y, Satozono Y, Shinmura M, Koreeda Y, Mizuno K, Inoue H. Hagihara Y, et al. Among authors: inoue h. Respir Investig. 2024 Jan;62(1):13-15. doi: 10.1016/j.resinv.2023.09.006. Epub 2023 Nov 3. Respir Investig. 2024. PMID: 37925883

8

Asthma control conundrum in clinical practice - Data from a two-stage Delphi survey and literature review.

Canonica GW, Spanevello A, de Llano LP, Ribas CD, Blakey JD, Garcia G, Inoue H, Dalcolmo M, Yang D, Mokashi S, Kurne A, Butta AK. Canonica GW, et al. Among authors: inoue h. Data Brief. 2023 Jul 18;50:109422. doi: 10.1016/j.dib.2023.109422. eCollection 2023 Oct. Data Brief. 2023. PMID: 37663766 Free PMC article.

9

Exacerbation rates in Japanese patients with obstructive lung disease: A subanalysis of the prospective, observational NOVELTY study.

Kawayama T, Takahashi K, Ikeda T, Fukui K, Makita N, Tashiro N, Saito J, Shirai T, Inoue H. Kawayama T, et al. Among authors: inoue h. Allergol Int. 2024 Jan;73(1):71-80. doi: 10.1016/j.alit.2023.08.003. Epub 2023 Sep 1. Allergol Int. 2024. PMID: 37661518 Free article.

10

Minichromosome maintenance proteins in lung adenocarcinoma: Clinical significance and therapeutic targets.

Tanigawa K, Tomioka Y, Misono S, Asai S, Kikkawa N, Hagihara Y, Suetsugu T, Inoue H, Mizuno K, Seki N. Tanigawa K, et al. Among authors: inoue h. FEBS Open Bio. 2023 Sep;13(9):1737-1755. doi: 10.1002/2211-5463.13681. Epub 2023 Aug 7. FEBS Open Bio. 2023. PMID: 37517032 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

236 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

236 results

Results by year